1Calder, PC, Albers, R, Antoine, JM, et al. (2009) Inflammatory disease processes and interactions with nutrition. Br J Nutr 101, Suppl. 1, S1–45.
2Kolb, H & Mandrup-Poulsen, T (2010) The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 53, 10–20.
3Fernandez-Real, JM & Pickup, JC (2008) Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 19, 10–16.
4Herder, C, Peltonen, M, Koenig, W, et al. (2006) Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes 55, 2340–2346.
5Herder, C, Illig, T, Rathmann, W, et al. (2005) Inflammation and type 2 diabetes: results from KORA Augsburg. Gesundheitswesen 67, Suppl. 1, S115–S121.
6Muller, S, Martin, S, Koenig, W, et al. (2002) Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45, 805–812.
7Kim, CS, Park, HS, Kawada, T, et al. (2006) Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30, 1347–1355.
8Hotamisligil, GS, Shargill, NS & Spiegelman, BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87–91.
9Trayhurn, P & Wood, IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347–355.
10Tilg, H & Moschen, AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6, 772–783.
11Wellen, KE & Hotamisligil, GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112, 1785–1788.
12Koerner, A, Kratzsch, J & Kiess, W (2005) Adipocytokines: leptin–the classical, resistin–the controversical, adiponectin–the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19, 525–546.
13Trujillo, ME & Scherer, PE (2006) Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27, 762–778.
14Stofkova, A (2009) Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 43, 157–168.
15Gil-Campos, M, Canete, RR & Gil, A (2004) Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23, 963–974.
16Fukuhara, A, Matsuda, M, Nishizawa, M, et al. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426–430.
17McTernan, PG, Kusminski, CM & Kumar, S (2006) Resistin. Curr Opin Lipidol 17, 170–175.
18Yang, RZ, Lee, MJ, Hu, H, et al. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290, E1253–E1261.
19Yang, RZ, Lee, MJ, Hu, H, et al. (2006) Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 3, e287.
20Sethi, JK & Vidal-Puig, A (2005) Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med 11, 344–347.
21Stephens, JM & Vidal-Puig, AJ (2006) An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr Opin Lipidol 17, 128–131.
22Juhan-Vague, I, Alessi, MC, Mavri, A, et al. (2003) Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 1, 1575–1579.
23Poitou, C, Viguerie, N, Cancello, R, et al. (2005) Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 48, 519–528.
24Somm, E, Cettour-Rose, P, Asensio, C, et al. (2006) Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 49, 387–393.
25Somm, E, Henrichot, E, Pernin, A, et al. (2005) Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure. Diabetes 54, 3503–3509.
26Meier, CA, Bobbioni, E, Gabay, C, et al. (2002) IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 87, 1184–1188.
27Netea, MG, Joosten, LA, Lewis, E, et al. (2006) Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 12, 650–656.
28Skurk, T, Kolb, H, Muller-Scholze, S, et al. (2005) The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 152, 863–868.
29Skurk, T, berti-Huber, C, Herder, C, et al. (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92, 1023–1033.
30Straczkowski, M, Kowalska, I, Nikolajuk, A, et al. (2007) Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Int J Obes (Lond) 31, 221–225.
31Cancello, R, Henegar, C, Viguerie, N, et al. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277–2286.
32Juge-Aubry, CE, Somm, E, Pernin, A, et al. (2005) Adipose tissue is a regulated source of interleukin-10. Cytokine 29, 270–274.
33Skurk, T, Herder, C, Kraft, I, et al. (2005) Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146, 1006–1011.
34Straczkowski, M, Dzienis-Straczkowska, S, Stepien, A, et al. (2002) Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 87, 4602–4606.
35Straczkowski, M, Kowalska, I, Nikolajuk, A, et al. (2003) Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol 2, 5.
36Curat, CA, Wegner, V, Sengenes, C, et al. (2006) Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49, 744–747.
37Herder, C, Hauner, H, Kempf, K, et al. (2007) Constitutive and regulated expression and secretion of interferon-gamma-inducible protein 10 (IP-10/CXCL10) in human adipocytes. Int J Obes (Lond) 31, 403–410.
38Fain, JN, Tichansky, DS & Madan, AK (2005) Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism 54, 1546–1551.
39Gabrielsson, BG, Johansson, JM, Lonn, M, et al. (2003) High expression of complement components in omental adipose tissue in obese men. Obes Res 11, 699–708.
40Guerre-Millo, M (2006) Adipose tissue secretory function: implication in metabolic and cardiovascular complications of obesity. J Soc Biol 200, 37–43.
41Graham, TE, Yang, Q, Bluher, M, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354, 2552–2563.
42Yang, Q, Graham, TE, Mody, N, et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356–362.
43Janke, J, Engeli, S, Boschmann, M, et al. (2006) Retinol-binding protein 4 in human obesity. Diabetes 55, 2805–2810.
44Carey, VJ, Walters, EE, Colditz, GA, et al. (1997) Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol 145, 614–619.
45Kissebah, AH, Vydelingum, N, Murray, R, et al. (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54, 254–260.
46Visser, M, Bouter, LM, McQuillan, GM, et al. (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131–2135.
47Cook, DG, Mendall, MA, Whincup, PH, et al. (2000) C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149, 139–150.
48Yudkin, JS (2003) Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 27, Suppl. 3, S25–S28.
49Wellen, KE & Hotamisligil, GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111–1119.
50Despres, JP & Lemieux, I (2006) Abdominal obesity and metabolic syndrome. Nature 444, 881–887.
51Lafontan, M & Girard, J (2008) Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab 34, 317–327.
52van Harmelen, V, Dicker, A, Ryden, M, et al. (2002) Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51, 2029–2036.
53Alessi, MC, Bastelica, D, Morange, P, et al. (2000) Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49, 1374–1380.
54Bruun, JM, Lihn, AS, Madan, AK, et al. (2004) Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 286, E8–E13.
55Bastelica, D, Morange, P, Berthet, B, et al. (2002) Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 22, 173–178.
56Fain, JN, Madan, AK, Hiler, ML, et al. (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273–2282.
57Hauner, H (2005) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64, 163–169.
58de Souza Batista, CM, Yang, RZ, Lee, MJ, et al. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56, 1655–1661.
59Arner, P (2006) Visfatin–a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 91, 28–30.
60Rabkin, SW (2007) Epicardial fat: properties, function and relationship to obesity. Obes Rev 8, 253–261.
61Silaghi, A, Piercecchi-Marti, MD, Grino, M, et al. (2008) Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity (Silver Spring) 16, 2424–2430.
62Jernas, M, Palming, J, Sjoholm, K, et al. (2006) Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 20, 1540–1542.
63Weyer, C, Foley, JE, Bogardus, C, et al. (2000) Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43, 1498–1506.
64Fain, JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74, 443–477.
65Cancello, R, Tordjman, J, Poitou, C, et al. (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55, 1554–1561.
66Weisberg, SP, McCann, D, Desai, M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
67Xu, H, Barnes, GT, Yang, Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821–1830.
68Henegar, C, Tordjman, J, Achard, V, et al. (2008) Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9, R14.
69Kintscher, U, Hartge, M, Hess, K, et al. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28, 1304–1310.
70Rausch, ME, Weisberg, S, Vardhana, P, et al. (2008) Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 32, 451–463.
71Wu, H, Ghosh, S, Perrard, XD, et al. (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115, 1029–1038.
72Bornstein, SR, Abu-Asab, M, Glasow, A, et al. (2000) Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes 49, 532–538.
73Cousin, B, Munoz, O, Andre, M, et al. (1999) A role for preadipocytes as macrophage-like cells. FASEB J 13, 305–312.
74Cousin, B, Andre, M, Casteilla, L, et al. (2001) Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol 186, 380–386.
75Lumeng, CN, Bodzin, JL & Saltiel, AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117, 175–184.
76Olefsky, JM & Glass, CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72, 219–246.
77Karastergiou, K & Mohamed-Ali, V (2010) The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol 318, 69–78.
78Curat, CA, Miranville, A, Sengenes, C, et al. (2004) From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53, 1285–1292.
79Guzik, TJ, Mangalat, D & Korbut, R (2006) Adipocytokines – novel link between inflammation and vascular function? J Physiol Pharmacol 57, 505–528.
80Weisberg, SP, Hunter, D, Huber, R, et al. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116, 115–124.
81Inouye, KE, Shi, H, Howard, JK, et al. (2007) Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56, 2242–2250.
82Trayhurn, P, Wang, B & Wood, IS (2008) Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100, 227–235.
83Guerre-Millo, M, Grosfeld, A & Issad, T (2002) Leptin is a hypoxia-inducible gene. Obes Res 10, 856–858.
84Cinti, S, Mitchell, G, Barbatelli, G, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46, 2347–2355.
85Bouloumie, A, Casteilla, L & Lafontan, M (2008) Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first? Arterioscler Thromb Vasc Biol 28, 1211–1213.
86Lagathu, C, Bastard, JP, Auclair, M, et al. (2003) Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 311, 372–379.
87Lacasa, D, Taleb, S, Keophiphath, M, et al. (2007) Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148, 868–877.
88Constant, VA, Gagnon, A, Landry, A, et al. (2006) Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49, 1402–1411.
89Permana, PA, Menge, C & Reaven, PD (2006) Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341, 507–514.
90Suganami, T, Nishida, J & Ogawa, Y (2005) A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25, 2062–2068.
91Kumar, A, Takada, Y, Boriek, AM, et al. (2004) Nuclear factor-kappaB: its role in health and disease. J Mol Med 82, 434–448.
92Perkins, ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8, 49–62.
93Sigal, LH (2006) Basic science for the clinician 39: NF-kappaB-function, activation, control, and consequences. J Clin Rheumatol 12, 207–211.
94Maury, E & Brichard, SM (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314, 1–16.
95Suganami, T, Tanimoto-Koyama, K, Nishida, J, et al. (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27, 84–91.
96Lin, Y, Lee, H, Berg, AH, et al. (2000) The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 275, 24255–24263.
97Shi, H, Kokoeva, MV, Inouye, K, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116, 3015–3025.
98Matsuzawa, Y (2006) The metabolic syndrome and adipocytokines. FEBS Lett 580, 2917–2921.
99Matsuzawa, Y (2006) Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3, 35–42.
100Chen, H (2006) Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol Res 53, 469–477.
101Malavazos, AE, Cereda, E, Morricone, L, et al. (2005) Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur J Endocrinol 153, 871–877.
102Malavazos, AE, Corsi, MM, Ermetici, F, et al. (2007) Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 17, 294–302.
103Ouchi, N, Kihara, S, Funahashi, T, et al. (2003) Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14, 561–566.
104Herder, C, Haastert, B, Muller-Scholze, S, et al. (2005) Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54, Suppl. 2, S11–S17.
105Stentz, FB, Umpierrez, GE, Cuervo, R, et al. (2004) Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53, 2079–2086.
106de Luca, C & Olefsky, JM (2006) Stressed out about obesity and insulin resistance. Nat Med 12, 41–42.
107Harman-Boehm, I, Bluher, M, Redel, H, et al. (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92, 2240–2247.
108Berg, AH & Scherer, PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96, 939–949.
109Kopelman, P (2007) Health risks associated with overweight and obesity. Obes Rev 8, Suppl. 1, 13–17.
110Ziccardi, P, Nappo, F, Giugliano, G, et al. (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105, 804–809.
111Esposito, K, Pontillo, A, Di Palo, C, et al. (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289, 1799–1804.
112Heilbronn, LK & Clifton, PM (2002) C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. J Nutr Biochem 13, 316–321.
113Bastard, JP, Jardel, C, Bruckert, E, et al. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338–3342.
114Esposito, K, Pontillo, A, Ciotola, M, et al. (2002) Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 87, 3864–3866.
115Bastard, JP, Vidal, H, Jardel, C, et al. (2000) Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects. Int J Obes Relat Metab Disord 24, 70–74.
116Gomez-Ambrosi, J, Salvador, J, Rotellar, F, et al. (2006) Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg 16, 262–269.
117Taleb, S, Cancello, R, Poitou, C, et al. (2006) Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women. J Clin Endocrinol Metab 91, 1042–1047.
118Laimer, M, Kaser, S, Kranebitter, M, et al. (2005) Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women. Int J Obes (Lond) 29, 498–501.
119Kopp, CW, Kopp, HP, Steiner, S, et al. (2003) Weight loss reduces tissue factor in morbidly obese patients. Obes Res 11, 950–956.
120Church, TS, Willis, MS, Priest, EL, et al. (2005) Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes (Lond) 29, 675–681.
121Christiansen, T, Richelsen, B & Bruun, JM (2005) Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29, 146–150.
122Vasudevan, AR, Wu, H, Xydakis, AM, et al. (2006) Eotaxin and obesity. J Clin Endocrinol Metab 91, 256–261.
123Krzyzanowska, K, Mittermayer, F, Krugluger, W, et al. (2006) Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring) 14, 1886–1889.
124Bastard, JP, Hainque, B, Dusserre, E, et al. (1999) Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women. Diabetes Metab Res Rev 15, 92–98.
125Kopp, HP, Kopp, CW, Festa, A, et al. (2003) Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23, 1042–1047.
126Poitou, C, Coussieu, C, Rouault, C, et al. (2006) Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity (Silver Spring) 14, 309–318.
127Clement, K, Viguerie, N, Poitou, C, et al. (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18, 1657–1669.
128de Luca, C & Olefsky, JM (2008) Inflammation and insulin resistance. FEBS Lett 582, 97–105.
129Li, L, Naples, M, Song, H, et al. (2007) LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling. Am J Physiol Endocrinol Metab 293, E587–E594.
130Rui, HL, Fan, E, Zhou, HM, et al. (2002) SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem 277, 42981–42986.
131Ueki, K, Kondo, T & Kahn, CR (2004) Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24, 5434–5446.
132Kim, JH, Kim, JE, Liu, HY, et al. (2008) Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem 283, 708–715.
133Lang, CH, Dobrescu, C & Bagby, GJ (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130, 43–52.
134Miles, PD, Romeo, OM, Higo, K, et al. (1997) TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46, 1678–1683.
135Atsumi, T, Cho, YR, Leng, L, et al. (2007) The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 179, 5399–5406.
136Houstis, N, Rosen, ED & Lander, ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944–948.
137Nishikawa, T, Kukidome, D, Sonoda, K, et al. (2007) Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract 77, Suppl. 1, S161–S164.
138Li, Y, Jiang, C, Xu, G, et al. (2008) Homocysteine upregulates resistin production from adipocytes in vivo and in vitro. Diabetes 57, 817–827.
139Arner, P (2005) Insulin resistance in type 2 diabetes – role of the adipokines. Curr Mol Med 5, 333–339.
140Yan, SF, Barile, GR, D'Agati, V, et al. (2007) The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications. Curr Diab Rep 7, 146–153.
141Nomiyama, T, Perez-Tilve, D, Ogawa, D, et al. (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117, 2877–2888.
142Clement, K & Langin, D (2007) Regulation of inflammation-related genes in human adipose tissue. J Intern Med 262, 422–430.
143Kim, JK, Kim, YJ, Fillmore, JJ, et al. (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108, 437–446.
144Yin, MJ, Yamamoto, Y & Gaynor, RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77–80.
145Shoelson, SE, Lee, J & Yuan, M (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27, Suppl. 3, S49–S52.
146Fleischman, A, Shoelson, SE, Bernier, R, et al. (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31, 289–294.
147Wasko, MC, Hubert, HB, Lingala, VB, et al. (2007) Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 298, 187–193.
148Larsen, CM, Faulenbach, M, Vaag, A, et al. (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356, 1517–1526.
149Barbuio, R, Milanski, M, Bertolo, MB, et al. (2007) Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol 194, 539–550.
150Dominguez, H, Storgaard, H, Rask-Madsen, C, et al. (2005) Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res 42, 517–525.
151Tam, LS, Tomlinson, B, Chu, TT, et al. (2007) Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 26, 1495–1498.
152Di Rocco, P, Manco, M, Rosa, G, et al. (2004) Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Obes Res 12, 734–739.
153Borst, SE, Lee, Y, Conover, CF, et al. (2004) Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue. Am J Physiol Endocrinol Metab 287, E934–E938.
154Hansen, K, Sickelmann, F, Pietrowsky, R, et al. (1997) Systemic immune changes following meal intake in humans. Am J Physiol 273, R548–R553.
155Plat, J, Jellema, A, Ramakers, J, et al. (2007) Weight loss, but not fish oil consumption, improves fasting and postprandial serum lipids, markers of endothelial function, and inflammatory signatures in moderately obese men. J Nutr 137, 2635–2640.
156Bell, DS, O'Keefe, JH & Jellinger, P (2008) Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events? Endocr Pract 14, 112–124.
157O'Keefe, JH, Gheewala, NM & O'Keefe, JO (2008) Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 51, 249–255.
158Napolitano, M & Bravo, E (2005) Lipid metabolism and TNF-alpha secretion in response to dietary sterols in human monocyte derived macrophages. Eur J Clin Invest 35, 482–490.
159van Oostrom, AJ, Sijmonsma, TP, Verseyden, C, et al. (2003) Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 44, 576–583.
160Luu, NT, Madden, J, Calder, PC, et al. (2007) Dietary supplementation with fish oil modifies the ability of human monocytes to induce an inflammatory response. J Nutr 137, 2769–2774.
161Alipour, A, van Oostrom, AJ, Izraeljan, A, et al. (2008) Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol 28, 792–797.
162Burdge, GC & Calder, PC (2005) Plasma cytokine response during the postprandial period: a potential causal process in vascular disease? Br J Nutr 93, 3–9.
163Manning, PJ, Sutherland, WH, McGrath, MM, et al. (2008) Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 16, 2046–2052.
164Jellema, A, Plat, J & Mensink, RP (2004) Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 34, 766–773.
165Esposito, K, Ciotola, M, Sasso, FC, et al. (2007) Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: role of tumor necrosis factor-alpha. Nutr Metab Cardiovasc Dis 17, 274–279.
166Nappo, F, Esposito, K, Cioffi, M, et al. (2002) Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 39, 1145–1150.
167Ceriello, A, Assaloni, R, Da, RR, et al. (2005) Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111, 2518–2524.
168Erridge, C, Attina, T, Spickett, CM, et al. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286–1292.
169Ceriello, A, Bortolotti, N, Motz, E, et al. (1998) Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21, 1529–1533.
170Wellen, KE, Fucho, R, Gregor, MF, et al. (2007) Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129, 537–548.
171Abedini, A & Shoelson, SE (2007) Inflammation and obesity: STAMPing out insulin resistance? Immunol Cell Biol 85, 399–400.
172Candore, G, Colonna-Romano, G, Balistreri, CR, et al. (2006) Biology of longevity: role of the innate immune system. Rejuvenation Res 9, 143–148.
173Krabbe, KS, Pedersen, M & Bruunsgaard, H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39, 687–699.
174Wei, J, Xu, H, Davies, JL, et al. (1992) Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 51, 1953–1956.
175Hager, K, Machein, U, Krieger, S, et al. (1994) Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 15, 771–772.
176Ferrucci, L, Corsi, A, Lauretani, F, et al. (2005) The origins of age-related proinflammatory state. Blood 105, 2294–2299.
177Pedersen, M, Bruunsgaard, H, Weis, N, et al. (2003) Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 124, 495–502.
178Paolisso, G, Rizzo, MR, Mazziotti, G, et al. (1998) Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 275, E294–E299.
179Bruunsgaard, H, Andersen-Ranberg, K, Jeune, B, et al. (1999) A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54, M357–M364.
180Ballou, SP, Lozanski, FB, Hodder, S, et al. (1996) Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 25, 224–230.
181Roubenoff, R, Harris, TB, Abad, LW, et al. (1998) Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 53, M20–M26.
182Franceschi, C, Capri, M, Monti, D, et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128, 92–105.
183Gangemi, S, Pescara, L, D'Urbano, E, et al. (2005) Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol 40, 612–614.
184Ahluwalia, N (2004) Aging, nutrition and immune function. J Nutr Health Aging 8, 2–6.
185Lesourd, B (2006) Nutritional factors and immunological ageing. Proc Nutr Soc 65, 319–325.
186Jenny, NS, Tracy, RP, Ogg, MS, et al. (2002) In the elderly, interleukin-6 plasma levels and the − 174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22, 2066–2071.
187Bruunsgaard, H (2002) Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 13, 389–391.
188Nakhai Pour, HR, Grobbee, DE, Muller, M, et al. (2007) Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men. Clin Endocrinol (Oxf) 66, 394–398.
189Guigoz, Y, Dore, J & Schiffrin, EJ (2008) The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 11, 13–20.
190Bruunsgaard, H, Ladelund, S, Pedersen, AN, et al. (2003) Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 132, 24–31.
191Harris, TB, Ferrucci, L, Tracy, RP, et al. (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106, 506–512.
192Reuben, DB, Cheh, AI, Harris, TB, et al. (2002) Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 50, 638–644.
193Volpato, S, Guralnik, JM, Ferrucci, L, et al. (2001) Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103, 947–953.
194Bruunsgaard, H, Pedersen, M & Pedersen, BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8, 131–136.
195Pate, RR, Pratt, M, Blair, SN, et al. (1995) Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273, 402–407.
196Caspersen, CJ, Powell, KE & Christenson, GM (1985) Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100, 126–131.
197Shephard, RJ, Allen, C, Benade, AJ, et al. (1968) The maximum oxygen intake. An international reference standard of cardiorespiratory fitness. Bull World Health Organ 38, 757–764.
198Hamer, M (2007) The relative influences of fitness and fatness on inflammatory factors. Prev Med 44, 3–11.
199Petersen, AM & Pedersen, BK (2005) The anti-inflammatory effect of exercise. J Appl Physiol 98, 1154–1162.
200Nicklas, BJ, You, T & Pahor, M (2005) Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ 172, 1199–1209.
201Kasapis, C & Thompson, PD (2005) The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 45, 1563–1569.
202Panagiotakos, DB, Kokkinos, P, Manios, Y, et al. (2004) Physical activity and markers of inflammation and thrombosis related to coronary heart disease. Prev Cardiol 7, 190–194.
203Tomaszewski, M, Charchar, FJ, Przybycin, M, et al. (2003) Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity: how low can you go? Arterioscler Thromb Vasc Biol 23, 1640–1644.
204Northoff, H, Weinstock, C & Berg, A (1994) The cytokine response to strenuous exercise. Int J Sports Med 15, Suppl. 3, S167–S171.
205Wärnberg, J, Nova, E, Romeo, J, et al. (2007) Lifestyle-related determinants of inflammation in adolescence. Br J Nutr 98, Suppl. 1, S116–S120.
206Pedersen, BK (2006) The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 42, 105–117.
207Pedersen, BK, Steensberg, A, Fischer, C, et al. (2003) Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24, 113–119.
208Fischer, CP, Berntsen, A, Perstrup, LB, et al. (2007) Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 17, 580–587.
209Ostrowski, K, Rohde, T, Zacho, M, et al. (1998) Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 508, Pt 3, 949–953.
210Fischer, CP (2006) Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 12, 6–33.
211Fallon, KE, Fallon, SK & Boston, T (2001) The acute phase response and exercise: court and field sports. Br J Sports Med 35, 170–173.
212Mattusch, F, Dufaux, B, Heine, O, et al. (2000) Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 21, 21–24.
213Hammett, CJ, Prapavessis, H, Baldi, JC, et al. (2006) Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk. Am Heart J 151, 367.
214Hammett, CJ, Oxenham, HC, Baldi, JC, et al. (2004) Effect of six months’ exercise training on C-reactive protein levels in healthy elderly subjects. J Am Coll Cardiol 44, 2411–2413.
215Bautmans, I, Njemini, R, Vasseur, S, et al. (2005) Biochemical changes in response to intensive resistance exercise training in the elderly. Gerontology 51, 253–265.
216Nicklas, BJ, Ambrosius, W, Messier, SP, et al. (2004) Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 79, 544–551.
217Marcell, TJ, McAuley, KA, Traustadottir, T, et al. (2005) Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism 54, 533–541.
218Fischer, CP, Plomgaard, P, Hansen, AK, et al. (2004) Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab 287, E1189–E1194.
219Kohut, ML, McCann, DA, Russell, DW, et al. (2006) Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 20, 201–209.
220Stewart, LK, Flynn, MG, Campbell, WW, et al. (2005) Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4. Brain Behav Immun 19, 389–397.
221Lakka, TA, Lakka, HM, Rankinen, T, et al. (2005) Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 26, 2018–2025.
222Pearson, TA, Mensah, GA, Alexander, RW, et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499–511.
223Elosua, R, Bartali, B, Ordovas, JM, et al. (2005) Association between physical activity, physical performance, and inflammatory biomarkers in an elderly population: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 60, 760–767.
224Colbert, LH, Visser, M, Simonsick, EM, et al. (2004) Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 52, 1098–1104.
225Wannamethee, SG, Lowe, GD, Whincup, PH, et al. (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105, 1785–1790.
226Reuben, DB, Judd-Hamilton, L, Harris, TB, et al. (2003) The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 51, 1125–1130.
227Geffken, DF, Cushman, M, Burke, GL, et al. (2001) Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 153, 242–250.
228Taaffe, DR, Harris, TB, Ferrucci, L, et al. (2000) Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 55, M709–M715.
229Albert, MA, Glynn, RJ & Ridker, PM (2004) Effect of physical activity on serum C-reactive protein. Am J Cardiol 93, 221–225.
230Jankord, R & Jemiolo, B (2004) Influence of physical activity on serum IL-6 and IL-10 levels in healthy older men. Med Sci Sports Exerc 36, 960–964.
231Cesari, M, Penninx, BW, Pahor, M, et al. (2004) Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59, 242–248.
232Visser, M, Pahor, M, Taaffe, DR, et al. (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57, M326–M332.
233Smith, JK, Dykes, R, Douglas, JE, et al. (1999) Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 281, 1722–1727.
234Goldhammer, E, Tanchilevitch, A, Maor, I, et al. (2005) Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 100, 93–99.
235Tisi, PV, Hulse, M, Chulakadabba, A, et al. (1997) Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 14, 344–350.
236Milani, RV, Lavie, CJ & Mehra, MR (2004) Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 43, 1056–1061.
237McGavock, JM, Mandic, S, Vonder Muhll, I, et al. (2004) Low cardiorespiratory fitness is associated with elevated C-reactive protein levels in women with type 2 diabetes. Diabetes Care 27, 320–325.
238Aronson, D, Sella, R, Sheikh-Ahmad, M, et al. (2004) The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol 44, 2003–2007.
239Aronson, D, Sheikh-Ahmad, M, Avizohar, O, et al. (2004) C-Reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis 176, 173–179.
240Panagiotakos, DB, Pitsavos, C, Chrysohoou, C, et al. (2005) The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA Study. Prev Med 40, 432–437.
241Abramson, JL & Vaccarino, V (2002) Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 162, 1286–1292.
242King, DE, Carek, P, Mainous, AG III, et al. (2003) Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 35, 575–581.
243Pischon, T, Hankinson, SE, Hotamisligil, GS, et al. (2003) Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res 11, 1055–1064.
244Mora, S, Lee, IM, Buring, JE, et al. (2006) Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 295, 1412–1419.
245Rawson, ES, Freedson, PS, Osganian, SK, et al. (2003) Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc 35, 1160–1166.
246Verdaet, D, Dendale, P, De, BD, et al. (2004) Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease. Atherosclerosis 176, 303–310.
247Raitakari, M, Mansikkaniemi, K, Marniemi, J, et al. (2005) Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study. J Intern Med 258, 428–434.
248Church, TS, Barlow, CE, Earnest, CP, et al. (2002) Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol 22, 1869–1876.
249Church, TS, Finley, CE, Earnest, CP, et al. (2002) Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obes Relat Metab Disord 26, 805–813.
250Diaz, VA, Player, MS, Mainous, AG III, et al. (2006) Competing impact of excess weight versus cardiorespiratory fitness on cardiovascular risk. Am J Cardiol 98, 1468–1471.
251Isasi, CR, Deckelbaum, RJ, Tracy, RP, et al. (2003) Physical fitness and C-reactive protein level in children and young adults: the Columbia University BioMarkers Study. Pediatrics 111, 332–338.
252Nemet, D, Wang, P, Funahashi, T, et al. (2003) Adipocytokines, body composition, and fitness in children. Pediatr Res 53, 148–152.
253Halle, M, Korsten-Reck, U, Wolfarth, B, et al. (2004) Low-grade systemic inflammation in overweight children: impact of physical fitness. Exerc Immunol Rev 10, 66–74.
254Kelly, AS, Wetzsteon, RJ, Kaiser, DR, et al. (2004) Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. J Pediatr 145, 731–736.
255Williams, MJ, Milne, BJ, Hancox, RJ, et al. (2005) C-reactive protein and cardiorespiratory fitness in young adults. Eur J Cardiovasc Prev Rehabil 12, 216–220.
256Platat, C, Wagner, A, Klumpp, T, et al. (2006) Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents. Diabetologia 49, 2078–2085.
257Ruiz, JR, Ortega, FB & Warnberg, J (2007) Associations of low-grade inflammation with physical activity, fitness and fatness in prepubertal children; the European Youth Heart Study. Int J Obes (Lond) 31, 1545–1551.
258Wärnberg, J (2006) .
259Thomas, NE, Baker, JS, Graham, MR, et al. (2008) C-reactive protein in schoolchildren and its relation to adiposity, physical activity, aerobic fitness and habitual diet. Br J Sports Med 42, 357–360.
260Ruiz, JR, Ortega, FB, Warnberg, J, et al. (2008) Inflammatory proteins and muscle strength in adolescents: the Avena study. Arch Pediatr Adolesc Med 162, 462–468.
261Dandona, P, Aljada, A, Chaudhuri, A, et al. (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448–1454.
262Moeller, SM, Reedy, J, Millen, AE, et al. (2007) Dietary patterns: challenges and opportunities in dietary patterns research an Experimental Biology workshop, April 1, 2006. J Am Diet Assoc 107, 1233–1239.
263Newby, PK, Muller, D, Hallfrisch, J, et al. (2003) Dietary patterns and changes in body mass index and waist circumference in adults. Am J Clin Nutr 77, 1417–1425.
264Michels, KB & Schulze, MB (2005) Can dietary patterns help us detect diet-disease associations? Nutr Res Rev 18, 241–248.
265Newby, PK & Tucker, KL (2004) Empirically derived eating patterns using factor or cluster analysis: a review. Nutr Rev 62, 177–203.
266Hu, FB (2002) Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 13, 3–9.
267Holloszy, JO & Fontana, L (2007) Caloric restriction in humans. Exp Gerontol 42, 709–712.
268Kolb, H & Mandrup-Poulsen, T (2005) An immune origin of type 2 diabetes? Diabetologia 48, 1038–1050.
269Johnson, JB, Summer, W, Cutler, RG, et al. (2007) Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 42, 665–674.
270Madsen, EL, Rissanen, A, Bruun, JM, et al. (2008) Weight loss larger than 10 % is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 158, 179–187.
271Guarente, L & Picard, F (2005) Calorie restriction–the SIR2 connection. Cell 120, 473–482.
272Dali-Youcef, N, Lagouge, M, Froelich, S, et al. (2007) Sirtuins: the ‘magnificent seven’, function, metabolism and longevity. Ann Med 39, 335–345.
273Yamamoto, H, Schoonjans, K & Auwerx, J (2007) Sirtuin functions in health and disease. Mol Endocrinol 21, 1745–1755.
274Salminen, A, Ojala, J, Huuskonen, J, et al. (2008) Interaction of aging-associated signaling cascades: inhibition of NF-kappaB signaling by longevity factors FoxOs and SIRT1. Cell Mol Life Sci 65, 1049–1058.
275Buteau, J & Accili, D (2007) Regulation of pancreatic beta-cell function by the forkhead protein FoxO1. Diabetes Obes Metab 9, Suppl. 2, 140–146.
276Huang, H & Tindall, DJ (2007) CDK2 and FOXO1: a fork in the road for cell fate decisions. Cell Cycle 6, 902–906.
277Kim, DH, Kim, JY, Yu, BP, et al. (2008) The activation of NF-kappaB through Akt-induced FOXO1 phosphorylation during aging and its modulation by calorie restriction. Biogerontology 9, 33–47.
278Nakae, J, Oki, M & Cao, Y (2008) The FoxO transcription factors and metabolic regulation. FEBS Lett 582, 54–67.
279Sharman, MJ & Volek, JS (2004) Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond) 107, 365–369.
280Baur, JA, Pearson, KJ, Price, NL, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–342.
281Baur, JA & Sinclair, DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493–506.
282Dai, J, Miller, AH, Bremner, JD, et al. (2008) Adherence to the Mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study. Circulation 117, 169–175.
283Chrysohoou, C, Panagiotakos, DB, Pitsavos, C, et al. (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 44, 152–158.
284Esposito, K, Marfella, R, Ciotola, M, et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440–1446.
285Fung, TT, McCullough, ML, Newby, PK, et al. (2005) Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 82, 163–173.
286Trichopoulou, A, Costacou, T, Bamia, C, et al. (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348, 2599–2608.
287Pitsavos, C, Panagiotakos, DB, Tzima, N, et al. (2007) Diet, exercise, and C-reactive protein levels in people with abdominal obesity: the ATTICA epidemiological study. Angiology 58, 225–233.
288Salas-Salvado, J, Garcia-Arellano, A, Estruch, R, et al. (2008) Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur J Clin Nutr 62, 651–659.
289Ambring, A, Johansson, M, Axelsen, M, et al. (2006) Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. Am J Clin Nutr 83, 575–581.
290Bellido, C, Lopez-Miranda, J, Perez-Martinez, P, et al. (2006) The Mediterranean and CHO diets decrease VCAM-1 and E-selectin expression induced by modified low-density lipoprotein in HUVECs. Nutr Metab Cardiovasc Dis 16, 524–530.
291Esposito, K, Ciotola, M, Giugliano, F, et al. (2006) Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 18, 405–410.
292Esposito, K, Ciotola, M, Giugliano, F, et al. (2007) Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res 19, 486–491.
293Estruch, R, Martinez-Gonzalez, MA, Corella, D, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1–11.
294Krajcovicova-Kudlackova, M & Blazicek, P (2005) C-reactive protein and nutrition. Bratisl Lek Listy 106, 345–347.
295Szeto, YT, Kwok, TC & Benzie, IF (2004) Effects of a long-term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk. Nutrition 20, 863–866.
296Purschwitz, K, Rassoul, F, Reuter, W, et al. (2001) Soluble leukocyte adhesion molecules in vegetarians of various ages. Z Gerontol Geriatr 34, 476–479.
297Kennedy, E, Ohls, J, Carlon, S, et al. (1994) The Healthy Eating Index Final Report. Alexandria, VA: Food and Nutrition Service, US Department of Agriculture.
298McCullough, ML, Feskanich, D, Stampfer, MJ, et al. (2002) Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76, 1261–1271.
299Haines, PS, Siega-Riz, AM & Popkin, BM (1999) The Diet Quality Index revised: a measurement instrument for populations. J Am Diet Assoc 99, 697–704.
300Ford, ES, Mokdad, AH & Liu, S (2005) Healthy Eating Index and C-reactive protein concentration: findings from the National Health and Nutrition Examination Survey III, 1988–1994. Eur J Clin Nutr 59, 278–283.
301Fargnoli, JL, Fung, TT, Olenczuk, DM, et al. (2008) Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses’ Health Study. Am J Clin Nutr 88, 1213–1224.
302Boynton, A, Neuhouser, ML, Wener, MH, et al. (2007) Associations between healthy eating patterns and immune function or inflammation in overweight or obese postmenopausal women. Am J Clin Nutr 86, 1445–1455.
303Lopez-Garcia, E, Schulze, MB, Fung, TT, et al. (2004) Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 80, 1029–1035.
304Schulze, MB, Hoffmann, K, Manson, JE, et al. (2005) Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 82, 675–684.
305Hoebeeck, LI, Rietzschel, ER, Langlois, M, et al. (2011) The relationship between diet and subclinical atherosclerosis: results from the Asklepios Study. Eur J Clin Nutr 65, 606–613.
306Nettleton, JA, Steffen, LM, Mayer-Davis, EJ, et al. (2006) Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 83, 1369–1379.
307Esmaillzadeh, A, Kimiagar, M, Mehrabi, Y, et al. (2007) Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr 137, 992–998.
308Nanri, A, Yoshida, D, Yamaji, T, et al. (2008) Dietary patterns and C-reactive protein in Japanese men and women. Am J Clin Nutr 87, 1488–1496.
309Nettleton, JA, Matijevic, N, Follis, JL, et al. (2010) Associations between dietary patterns and flow cytometry-measured biomarkers of inflammation and cellular activation in the Atherosclerosis Risk in Communities (ARIC) Carotid Artery MRI Study. Atherosclerosis 212, 260–267.
310Jensen, MK, Koh-Banerjee, P, Franz, M, et al. (2006) Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1. Am J Clin Nutr 83, 275–283.
311Lutsey, PL, Jacobs, DR Jr, Kori, S, et al. (2007) Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: The MESA Study. Br J Nutr 98, 397–405.
312Mantzoros, CS, Williams, CJ, Manson, JE, et al. (2006) Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 84, 328–335.
313Masters, RC, Liese, AD, Haffner, SM, et al. (2010) Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma. J Nutr 140, 587–594.
314Qi, L, van Dam, RM, Liu, S, et al. (2006) Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29, 207–211.
315Qi, L, Rimm, E, Liu, S, et al. (2005) Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 28, 1022–1028.
316Andersson, A, Tengblad, S, Karlstrom, B, et al. (2007) Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J Nutr 137, 1401–1407.
317Brownlee, IA, Moore, C, Chatfield, M, et al. (2010) Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. Br J Nutr 104, 125–134.
318Esposito, K, Nappo, F, Giugliano, F, et al. (2003) Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78, 1135–1140.
319Katcher, HI, Legro, RS, Kunselman, AR, et al. (2008) The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr 87, 79–90.
320Tighe, P, Duthie, G, Vaughan, N, et al. (2010) Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr 92, 733–740.
321Mateo, AN, Aura, AM, Selinheimo, E, et al. (2011) Bioprocessing of wheat bran in whole wheat bread increases the bioavailability of phenolic acids in men and exerts antiinflammatory effects ex vivo. J Nutr 141, 137–143.
322Bhupathiraju, SN & Tucker, KL (2011) Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults. Am J Clin Nutr 93, 37–46.
323Chun, OK, Chung, SJ, Claycombe, KJ, et al. (2008) Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr 138, 753–760.
324Esmaillzadeh, A, Kimiagar, M, Mehrabi, Y, et al. (2006) Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 84, 1489–1497.
325Gao, X, Bermudez, OI & Tucker, KL (2004) Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr 134, 913–918.
326Hermsdorff, HH, Zulet, MA, Puchau, B, et al. (2010) Fruit and vegetable consumption and proinflammatory gene expression from peripheral blood mononuclear cells in young adults: a translational study. Nutr Metab (Lond) 7, 42.
327Holt, EM, Steffen, LM, Moran, A, et al. (2009) Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc 109, 414–421.
328Oliveira, A, Rodriguez-Artalejo, F & Lopes, C (2009) The association of fruits, vegetables, antioxidant vitamins and fibre intake with high-sensitivity C-reactive protein: sex and body mass index interactions. Eur J Clin Nutr 63, 1345–1352.
329Wannamethee, SG, Lowe, GD, Rumley, A, et al. (2006) Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr 83, 567–574.
330Yannakoulia, M, Yiannakouris, N, Melistas, L, et al. (2008) Dietary factors associated with plasma high molecular weight and total adiponectin levels in apparently healthy women. Eur J Endocrinol 159, R5–R10.
331Basu, A, Du, M, Leyva, MJ, et al. (2010) Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 140, 1582–1587.
332Castilla, P, Echarri, R, Davalos, A, et al. (2006) Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 84, 252–262.
333Curtis, PJ, Kroon, PA, Hollands, WJ, et al. (2009) Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J Nutr 139, 2266–2271.
334Dalgard, C, Nielsen, F, Morrow, JD, et al. (2009) Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. Br J Nutr 101, 263–269.
335Esposito, K, Nappo, F, Giugliano, F, et al. (2003) Effect of dietary antioxidants on postprandial endothelial dysfunction induced by a high-fat meal in healthy subjects. Am J Clin Nutr 77, 139–143.
336Freese, R, Vaarala, O, Turpeinen, AM, et al. (2004) No difference in platelet activation or inflammation markers after diets rich or poor in vegetables, berries and apple in healthy subjects. Eur J Nutr 43, 175–182.
337Karlsen, A, Retterstol, L, Laake, P, et al. (2007) Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 137, 1951–1954.
338Karlsen, A, Paur, I, Bohn, SK, et al. (2010) Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr 49, 345–355.
339Kelley, DS, Rasooly, R, Jacob, RA, et al. (2006) Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 136, 981–986.
340Larmo, P, Alin, J, Salminen, E, et al. (2008) Effects of sea buckthorn berries on infections and inflammation: a double-blind, randomized, placebo-controlled trial. Eur J Clin Nutr 62, 1123–1130.
341Morand, C, Dubray, C, Milenkovic, D, et al. (2011) Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 93, 73–80.
342Sanchez-Moreno, C, Cano, MP, de, AB, et al. (2004) Consumption of high-pressurized vegetable soup increases plasma vitamin C and decreases oxidative stress and inflammatory biomarkers in healthy humans. J Nutr 134, 3021–3025.
343Sanchez-Moreno, C, Cano, MP, de, AB, et al. (2003) High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. J Nutr 133, 2204–2209.
344van Doorn, MB, Espirito Santo, SM, Meijer, P, et al. (2006) Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects. Am J Clin Nutr 84, 1324–1329.
345Watzl, B, Kulling, SE, Moseneder, J, et al. (2005) A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 82, 1052–1058.
346Zern, TL, Wood, RJ, Greene, C, et al. (2005) Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 135, 1911–1917.
347Azadbakht, L, Kimiagar, M, Mehrabi, Y, et al. (2007) Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 30, 967–973.
348Azadbakht, L, Atabak, S & Esmaillzadeh, A (2008) Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 31, 648–654.
349Beavers, KM, Serra, MC, Beavers, DP, et al. (2010) Soy and the exercise-induced inflammatory response in postmenopausal women. Appl Physiol Nutr Metab 35, 261–269.
350Beavers, KM, Serra, MC, Beavers, DP, et al. (2009) Soymilk supplementation does not alter plasma markers of inflammation and oxidative stress in postmenopausal women. Nutr Res 29, 616–622.
351Blum, A, Lang, N, Peleg, A, et al. (2003) Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J 145, e7.
352Charles, C, Yuskavage, J, Carlson, O, et al. (2009) Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 16, 395–400.
353Greany, KA, Nettleton, JA, Wangen, KE, et al. (2008) Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr 62, 1419–1425.
354Hanson, LN, Engelman, HM, Alekel, DL, et al. (2006) Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr 84, 774–780.
355Hilpert, KF, Kris-Etherton, PM & West, SG (2005) Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J Nutr 135, 1075–1079.
356Jenkins, DJ, Kendall, CW, Jackson, CJ, et al. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76, 365–372.
357Maskarinec, G, Steude, JS, Franke, AA, et al. (2009) Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond) 6, 9.
358Matthan, NR, Jalbert, SM, Ausman, LM, et al. (2007) Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 85, 960–966.
359McVeigh, BL, Dillingham, BL, Lampe, JW, et al. (2006) Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr 83, 244–251.
360Mukuddem-Petersen, J, Stonehouse, OW, Jerling, JC, et al. (2007) Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial. Br J Nutr 97, 1144–1153.
361Nasca, MM, Zhou, JR & Welty, FK (2008) Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 102, 84–86.
362Ryan-Borchers, TA, Park, JS, Chew, BP, et al. (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83, 1118–1125.
363Teede, HJ, Dalais, FS & McGrath, BP (2004) Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am J Clin Nutr 79, 396–401.
364Zemel, MB, Sun, X, Sobhani, T, et al. (2010) Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr 91, 16–22.
365Maskarinec, G, Oum, R, Chaptman, AK, et al. (2009) Inflammatory markers in a randomised soya intervention among men. Br J Nutr 101, 1740–1744.
366Napora, JK, Short, RG, Muller, DC, et al. (2011) High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer. J Androl 32, 40–48.
367Jiang, R, Jacobs, DR Jr, Mayer-Davis, E, et al. (2006) Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol 163, 222–231.
368Li, TY, Brennan, AM, Wedick, NM, et al. (2009) Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 139, 1333–1338.
369Sari, I, Baltaci, Y, Bagci, C, et al. (2010) Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition 26, 399–404.
370Rajaram, S, Connell, KM & Sabate, J (2010) Effect of almond-enriched high-monounsaturated fat diet on selected markers of inflammation: a randomised, controlled, crossover study. Br J Nutr 103, 907–912.
371Banel, DK & Hu, FB (2009) Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 90, 56–63.
372Ros, E (2009) Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 89, 1649S–1656S.
373Lopez-Garcia, E, Schulze, MB, Manson, JE, et al. (2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134, 1806–1811.
374Madsen, T, Skou, HA, Hansen, VE, et al. (2001) C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88, 1139–1142.
375King, DE, Egan, BM & Geesey, ME (2003) Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92, 1335–1339.
376Hickling, S, Hung, J, Knuiman, M, et al. (2008) Are the associations between diet and C-reactive protein independent of obesity? Prev Med 47, 71–76.
377Zampelas, A, Panagiotakos, DB, Pitsavos, C, et al. (2005) Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol 46, 120–124.
378Lindqvist, H, Langkilde, AM, Undeland, I, et al. (2007) Herring (Clupea harengus) supplemented diet influences risk factors for CVD in overweight subjects. Eur J Clin Nutr 61, 1106–1113.
379Maki, T, Pham, NM, Yoshida, D, et al. (2010) The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women. Clin Chem Lab Med 48, 849–854.
380De Bacquer, D, Clays, E, Delanghe, J, et al. (2006) Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammation. Atherosclerosis 189, 428–435.
381Basu, A, Du, M, Sanchez, K, et al. (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27, 206–213.
382de Maat, MP, Pijl, H, Kluft, C, et al. (2000) Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. Eur J Clin Nutr 54, 757–763.
383Fukino, Y, Ikeda, A, Maruyama, K, et al. (2008) Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 62, 953–960.
384Hodgson, JM, Puddey, IB, Mori, TA, et al. (2001) Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr 55, 881–886.
385Mukamal, KJ, MacDermott, K, Vinson, JA, et al. (2007) A 6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 154, 724–726.
386Ryu, OH, Lee, J, Lee, KW, et al. (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71, 356–358.
387Steptoe, A, Gibson, EL, Vuononvirta, R, et al. (2007) The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis 193, 277–282.
388Sung, H, Min, WK, Lee, W, et al. (2005) The effects of green tea ingestion over four weeks on atherosclerotic markers. Ann Clin Biochem 42, 292–297.
389Widlansky, ME, Duffy, SJ, Hamburg, NM, et al. (2005) Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic Biol Med 38, 499–506.
390Khan, N, Afaq, F, Saleem, M, et al. (2006) Targeting multiple signaling pathways by green tea polyphenol ( − )-epigallocatechin-3-gallate. Cancer Res 66, 2500–2505.
391Kim, SJ, Jeong, HJ, Lee, KM, et al. (2007) Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J Nutr Biochem 18, 587–596.
392Syed, DN, Afaq, F, Kweon, MH, et al. (2007) Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 26, 673–682.
393Feng, WY (2006) Metabolism of green tea catechins: an overview. Curr Drug Metab 7, 755–809.
394Renouf, M, Guy, P, Marmet, C, et al. (2010) Plasma appearance and correlation between coffee and green tea metabolites in human subjects. Br J Nutr 104, 1635–1640.
395Hamer, M, Williams, ED, Vuononvirta, R, et al. (2006) Association between coffee consumption and markers of inflammation and cardiovascular function during mental stress. J Hypertens 24, 2191–2197.
396Lopez-Garcia, E, van Dam, RM, Qi, L, et al. (2006) Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84, 888–893.
397Williams, CJ, Fargnoli, JL, Hwang, JJ, et al. (2008) Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 31, 504–507.
398Zampelas, A, Panagiotakos, DB, Pitsavos, C, et al. (2004) Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 80, 862–867.
399Rodrigues, IM & Klein, LC (2006) Boiled or filtered coffee? Effects of coffee and caffeine on cholesterol, fibrinogen and C-reactive protein. Toxicol Rev 25, 55–69.
400Bonita, JS, Mandarano, M, Shuta, D, et al. (2007) Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol Res 55, 187–198.
401Moisey, LL, Kacker, S, Bickerton, AC, et al. (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 87, 1254–1261.
402Lane, JD, Feinglos, MN & Surwit, RS (2008) Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes. Diabetes Care 31, 221–222.
403Battram, DS, Arthur, R, Weekes, A, et al. (2006) The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 136, 1276–1280.
404Kempf, K, Herder, C, Erlund, I, et al. (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91, 950–957.
405Adamson, GE, Lazarus, SA, Mitchell, AE, et al. (1999) HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J Agric Food Chem 47, 4184–4188.
406Hammerstone, JF, Lazarus, SA, Mitchell, AE, et al. (1999) Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem 47, 490–496.
407Natsume, M, Osakabe, N, Yamagishi, M, et al. (2000) Analyses of polyphenols in cacao liquor, cocoa, and chocolate by normal-phase and reversed-phase HPLC. Biosci Biotechnol Biochem 64, 2581–2587.
408Lazarus, SA, Adamson, GE, Hammerstone, JF, et al. (1999) High-performance liquid chromatography/mass spectrometry analysis of proanthocyanidins in foods and beverages. J Agric Food Chem 47, 3693–3701.
409Lazarus, SA, Hammerstone, JF & Schmitz, HH (1999) Chocolate contains additional flavonoids not found in tea. Lancet 354, 1825.
410Vinson, JA, Jang, J, Dabbagh, YA, et al. (1995) Plant polyphenols exhibit lipo-protein bound antioxidant activity using an in vitro oxidation model for heart disease. J Agric Food Chem 43, 2798–2799.
411Hammerstone, JF, Lazarus, SA & Schmitz, HH (2000) Procyanidin content and variation in some commonly consumed foods. J Nutr 130, 2086S–2092S.
412Mao, T, Van de Water, J, Keen, CL, et al. (2000) Cocoa procyanidins and human cytokine transcription and secretion. J Nutr 130, 2093S–2099S.
413Mao, TK, Powell, J, Van de Water, J, et al. (2000) The effect of cocoa procyanidins on the transcription and secretion of interleukin 1 beta in peripheral blood mononuclear cells. Life Sci 66, 1377–1386.
414di Giuseppe, R, Di Castelnuovo, A, Centritto, F, et al. (2008) Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr 138, 1939–1945.
415Mathur, S, Devaraj, S, Grundy, SM, et al. (2002) Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr 132, 3663–3667.
416Hamed, MS, Gambert, S, Bliden, KP, et al. (2008) Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med J 101, 1203–1208.
417Monagas, M, Khan, N, Andres-Lacueva, C, et al. (2009) Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr 90, 1144–1150.
418Albert, MA, Glynn, RJ & Ridker, PM (2003) Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107, 443–447.
419Alho, H, Sillanaukee, P, Kalela, A, et al. (2004) Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein. Alcohol Alcohol 39, 312–315.
420Averina, M, Nilssen, O, Arkhipovsky, VL, et al. (2006) C-reactive protein and alcohol consumption: Is there a U-shaped association? Results from a population-based study in Russia. The Arkhangelsk study. Atherosclerosis 188, 309–315.
421Bermudez, EA, Rifai, N, Buring, J, et al. (2002) Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22, 1668–1673.
422Englund, OL, Brohall, G, Behre, CJ, et al. (2006) Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care 29, 908–913.
423Gonzalez-Quintela, A, Alende, R, Gude, F, et al. (2008) Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 151, 42–50.
424Hoffmeister, A, Imhof, A, Rothenbacher, D, et al. (2003) Moderate alcohol consumption and plasma concentration of sensitive markers of inflammation. Comment on an atheroprotective relationship. Dtsch Med Wochenschr 128, 2237–2241.
425Imhof, A, Froehlich, M, Brenner, H, et al. (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357, 763–767.
426Imhof, A, Woodward, M, Doering, A, et al. (2004) Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 25, 2092–2100.
427Mukamal, KJ, Cushman, M, Mittleman, MA, et al. (2004) Alcohol consumption and inflammatory markers in older adults: the Cardiovascular Health Study. Atherosclerosis 173, 79–87.
428Pai, JK, Hankinson, SE, Thadhani, R, et al. (2006) Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 186, 113–120.
429Shai, I, Rimm, EB, Schulze, MB, et al. (2004) Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia 47, 1760–1767.
430Stewart, SH, Mainous, AG III & Gilbert, G (2002) Relation between alcohol consumption and C-reactive protein levels in the adult US population. J Am Board Fam Pract 15, 437–442.
431Volpato, S, Pahor, M, Ferrucci, L, et al. (2004) Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 109, 607–612.
432Wannamethee, SG, Lowe, GD, Shaper, G, et al. (2003) The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men. Thromb Haemost 90, 1080–1087.
433Beulens, JW, de Zoete, EC, Kok, FJ, et al. (2008) Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutr 62, 1098–1105.
434Beulens, JW, van den, BR, Kok, FJ, et al. (2008) Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity. Nutr Metab Cardiovasc Dis 18, 539–544.
435Watzl, B, Bub, A, Briviba, K, et al. (2002) Acute intake of moderate amounts of red wine or alcohol has no effect on the immune system of healthy men. Eur J Nutr 41, 264–270.
436Watzl, B, Bub, A, Pretzer, G, et al. (2004) Daily moderate amounts of red wine or alcohol have no effect on the immune system of healthy men. Eur J Clin Nutr 58, 40–45.
437Beulens, JW, van Beers, RM, Stolk, RP, et al. (2006) The effect of moderate alcohol consumption on fat distribution and adipocytokines. Obesity (Silver Spring) 14, 60–66.
438Blanco-Colio, LM, Valderrama, M, Alvarez-Sala, LA, et al. (2000) Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 102, 1020–1026.
439Blann, AD, Williams, NR, Lip, GY, et al. (2002) Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine. Blood Coagul Fibrinolysis 13, 647–651.
440Dhindsa, S, Tripathy, D, Mohanty, P, et al. (2004) Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism 53, 330–334.
441Gonzalez-Quintela, A, Dominguez-Santalla, MJ, Perez, LF, et al. (2000) Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine 12, 1437–1440.
442Greenfield, JR, Samaras, K, Hayward, CS, et al. (2005) Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab 90, 661–672.
443Pedersen, N, Larsen, S, Seidelin, JB, et al. (2004) Alcohol modulates circulating levels of interleukin-6 and monocyte chemoattractant protein-1 in chronic pancreatitis. Scand J Gastroenterol 39, 277–282.
444Retterstol, L, Berge, KE, Braaten, O, et al. (2005) A daily glass of red wine: does it affect markers of inflammation? Alcohol 40, 102–105.
445Sacanella, E, Vazquez-Agell, M, Mena, MP, et al. (2007) Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am J Clin Nutr 86, 1463–1469.
446Sierksma, A, van der Gaag, MS, Kluft, C, et al. (2002) Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 56, 1130–1136.
447Vazquez-Agell, M, Sacanella, E, Tobias, E, et al. (2007) Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr 137, 2279–2284.
448Williams, MJ, Sutherland, WH, Whelan, AP, et al. (2004) Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease. Metabolism 53, 318–323.
449Vlassara, H (2005) Advanced glycation in health and disease: role of the modern environment. Ann N Y Acad Sci 1043, 452–460.
450Vlassara, H & Striker, G (2007) Glycotoxins in the diet promote diabetes and diabetic complications. Curr Diab Rep 7, 235–241.
451Ames, JM (2007) Evidence against dietary advanced glycation endproducts being a risk to human health. Mol Nutr Food Res 51, 1085–1090.
452Henle, T (2007) Dietary advanced glycation end products – a risk to human health? A call for an interdisciplinary debate. Mol Nutr Food Res 51, 1075–1078.
453Sebekova, K & Somoza, V (2007) Dietary advanced glycation endproducts (AGEs) and their health effects–PRO. Mol Nutr Food Res 51, 1079–1084.
454Henle, T (2003) AGEs in foods: do they play a role in uremia? Kidney Int Suppl 63, S145–S147.
455Monnier, VM (2003) Intervention against the Maillard reaction in vivo. Arch Biochem Biophys 419, 1–15.
456Koschinsky, T, He, CJ, Mitsuhashi, T, et al. (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 94, 6474–6479.
457Sebekova, K, Podracka, L, Heidland, A, et al. (2001) Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents wi